Chlorthalidone Tablets recall (Inventia Healthcare Limited)
DrugClass IIOngoing
Summary: Inventia Healthcare Limited is recalling Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01. Reason: Failed Dissolution Specifications.
What is being recalled
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Why
Failed Dissolution Specifications
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
U.S. Nationwide
How to tell if yours is affected
Batch # RISA24002; Exp Date: 04/2027
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0852-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | September 3, 2026 |
| Reported | September 23, 2026 |
| Company | Inventia Healthcare Limited |
| Company location | Kalyan, N/A, India |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 13567 bottles |
More recalls from Inventia Healthcare Limited · all drug recalls · recalls from September 2026